BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

138 related articles for article (PubMed ID: 23083565)

  • 21. The challenge of imaging dense breast parenchyma: is magnetic resonance mammography the technique of choice? A comparative study with x-ray mammography and whole-breast ultrasound.
    Pediconi F; Catalano C; Roselli A; Dominelli V; Cagioli S; Karatasiou A; Pronio A; Kirchin MA; Passariello R
    Invest Radiol; 2009 Jul; 44(7):412-21. PubMed ID: 19448554
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Exploiting sparsity in x-f space for higher spatiotemporal resolution in breast dynamic contrast-enhanced (DCE)-MRI.
    Usman M; Ramsay EA; Siegler P; Plewes DB; Chan RW
    Eur J Radiol; 2012 Sep; 81 Suppl 1():S171-3. PubMed ID: 23083578
    [No Abstract]   [Full Text] [Related]  

  • 23. Wish list for future features of breast MRI computer aided evaluation.
    Kelcz F
    Eur J Radiol; 2012 Sep; 81 Suppl 1():S78-9. PubMed ID: 23083613
    [No Abstract]   [Full Text] [Related]  

  • 24. When is breast magnetic resonance imaging recommended for cancer detection?
    Miller JC; Rafferty EA; Specht MC; Thrall JH; Lee SI
    J Am Coll Radiol; 2008 Mar; 5(3):224-6. PubMed ID: 18312973
    [No Abstract]   [Full Text] [Related]  

  • 25. Supine breast MRI and assessment of future clinical applications.
    Siegler P; Ebrahimi M; Holloway CM; Thevathasan G; Plewes DB; Martel A
    Eur J Radiol; 2012 Sep; 81 Suppl 1():S153-5. PubMed ID: 23083571
    [No Abstract]   [Full Text] [Related]  

  • 26. New technologies in breast imaging.
    Patterson SK
    J Natl Compr Canc Netw; 2003 Apr; 1(2):272-8. PubMed ID: 19768885
    [TBL] [Abstract][Full Text] [Related]  

  • 27. [Methodological features of magnetic resonance imaging mammography].
    Kulakov VI; Panov VO; Volobuev AI; Rudneva TV; Stashuk GA
    Vestn Rentgenol Radiol; 2006; (1):4-18. PubMed ID: 17195628
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Primary neuroendocrine carcinoma of the breast: radiologic and pathologic correlation.
    Yoon YS; Kim SY; Lee JH; Kim SY; Han SW
    Clin Imaging; 2014; 38(5):734-8. PubMed ID: 25052497
    [TBL] [Abstract][Full Text] [Related]  

  • 29. An imaging approach to high-risk screening for breast cancer.
    Jochelson MS; Morris EA
    Semin Roentgenol; 2011 Jan; 46(1):68-75. PubMed ID: 21134530
    [No Abstract]   [Full Text] [Related]  

  • 30. Age-related structural and functional changes in the breast: multimodality correlation with digital mammography, computed tomography, magnetic resonance imaging, and positron emission tomography.
    Abramson RG; Mavi A; Cermik T; Basu S; Wehrli NE; Houseni M; Mishra S; Udupa J; Lakhani P; Maidment AD; Torigian DA; Alavi A
    Semin Nucl Med; 2007 May; 37(3):146-53. PubMed ID: 17418148
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Evolving role of imaging modalities in inflammatory breast cancer.
    Le-Petross CH; Bidaut L; Yang WT
    Semin Oncol; 2008 Feb; 35(1):51-63. PubMed ID: 18308146
    [TBL] [Abstract][Full Text] [Related]  

  • 32. The current status of positron emission mammography in breast cancer diagnosis.
    Kalles V; Zografos GC; Provatopoulou X; Koulocheri D; Gounaris A
    Breast Cancer; 2013 Apr; 20(2):123-30. PubMed ID: 23239242
    [TBL] [Abstract][Full Text] [Related]  

  • 33. MR-mammography: high sensitivity but low specificity? New thoughts and fresh data on an old mantra.
    Dietzel M; Baltzer PA; Schön K; Kaiser WA
    Eur J Radiol; 2012 Sep; 81 Suppl 1():S30-2. PubMed ID: 23083592
    [No Abstract]   [Full Text] [Related]  

  • 34. Advances in imaging of inflammatory breast cancer.
    Yang WT
    Cancer; 2010 Jun; 116(11 Suppl):2755-7. PubMed ID: 20503406
    [TBL] [Abstract][Full Text] [Related]  

  • 35. It is not all in the CAD or BI-RADS.
    Kelcz F
    Eur J Radiol; 2012 Sep; 81 Suppl 1():S76-7. PubMed ID: 23083612
    [No Abstract]   [Full Text] [Related]  

  • 36. Computed-aided diagnosis (CAD) in the detection of breast cancer.
    Dromain C; Boyer B; Ferré R; Canale S; Delaloge S; Balleyguier C
    Eur J Radiol; 2013 Mar; 82(3):417-23. PubMed ID: 22939365
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Do we really need new contrast agents for MR-mammography?
    Rachetta E; Spinelli R; Martincich L
    Eur J Radiol; 2012 Sep; 81 Suppl 1():S127-8. PubMed ID: 23083558
    [No Abstract]   [Full Text] [Related]  

  • 38. Potential of MR-mammography for identification of intraductual papillomas.
    Dietzel M; Baltzer PA; Kaiser WA
    Eur J Radiol; 2012 Sep; 81 Suppl 1():S33-4. PubMed ID: 23083593
    [No Abstract]   [Full Text] [Related]  

  • 39. Screening, imaging, and image-guided biopsy techniques for breast cancer.
    Smetherman DH
    Surg Clin North Am; 2013 Apr; 93(2):309-27. PubMed ID: 23464688
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Prospective study of the efficacy of breast magnetic resonance imaging and mammographic screening in survivors of Hodgkin lymphoma.
    Ng AK; Garber JE; Diller LR; Birdwell RL; Feng Y; Neuberg DS; Silver B; Fisher DC; Marcus KJ; Mauch PM
    J Clin Oncol; 2013 Jun; 31(18):2282-8. PubMed ID: 23610104
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.